Pfizer to spend $11.6B on migraine treatment maker Biohaven

May 10, 2022, 4:31 AM | Updated: 2:06 pm

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area.

The New York vaccine and cancer drug maker said Tuesday it will use cash on hand to buy the remaining portion of migraine treatment developer Biohaven Pharmaceutical it does not already own.

Pfizer will pay $148.50 in cash for each share of Biohaven, which makes Nurtec ODT for treating and preventing migraines and has a nasal spray under development.

Pfizer Inc. brought in more than $14 billion in sales during the recently completed first quarter from its COVID-19 vaccine Comirnaty and its new pill treatment for the virus, Paxlovid.

Most of that came from Comirnaty, which also rang up nearly $37 billion in sales last year. But revenue from Comirnaty, which Pifzer developed with BioNTech, is expected to fade in the coming years. Pfizer also faces the loss of patent protection for some key products in its broad portfolio over the next decade.

That includes Eliquis for preventing blood clots and strokes and the Prevnar 13 vaccine for preventing pneumonia and related bacterial diseases.

The company plans to have about $25 billion in sales by 2030 come from new business developments.

The deal announced Tuesday is a step in that direction. Pfizer currently has no migraine treatments. U.S. regulators approved Nurtec ODT — which stands for orally disintegrating tablet — for treating migraines in February 2020 and for preventing them about a year ago.

The drug is sold as Vydura in the European Union.

It brought in nearly $124 million in sales in the first quarter. Biohaven expects $825 to $900 million in product sales this year.

Pfizer plans to put its marketing muscle into the drug with potential launches for it in 70 countries.

Last November, Pfizer said it would invest $350 million in Biohaven to help sell Nurtec ODT and the spray, zavegepant, outside the United States.

Pfizer said Tuesday the spray is on track for U.S. acceptance in the current quarter, and an oral gel version of it also is being developed for preventing chronic migraines.

Pfizer executives told analysts they expect annual revenue from Nurtec ODT and the spray to eventually peak above $6 billion.

The pharmaceutical giant is an “ideal acquirer” of Biohaven’s portfolio in part because of its strong presence in primary care, its cash position and its need for new growth drivers, Mizuho Securities USA analyst Dr. Vamil Divan said in a research note.

The deal for Biohaven also includes some other potential treatments in early stages of development.

Other elements of Biohaven’s late-stage development pipeline will go to a new, publicly traded company that keeps the Biohaven name.

The boards of both Pfizer and Biohaven have approved the sale. Biohaven shareholders, who will receive a stake in the new company, and regulators still need to ok it.

The deal is expected to close by early 2023.

Shares of Biohaven Pharmaceutical Holding Company Ltd. which is based in New Haven, Connecticut, soared almost 70% to $141.20 in midday trading.

Pfizer’s stock climbed about 1% to $49.20 as broader trading indexes slipped.

___

Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy

___

The story has been corrected to show that Biohaven shareholders have yet to approve the agreement.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Haitian migrant Gerson Solay, 28, carries his daughter, Bianca, as he and his family cross into Can...
Associated Press

US, Canada to end loophole that allows asylum-seekers to move between countries

President Joe Biden and Canadian Prime Minister Justin Trudeau on Friday announced a plan to close a loophole to an immigration agreement.
2 days ago
Expert skateboarder Di'Orr Greenwood, an artist born and raised in the Navajo Nation in Arizona and...
Associated Press

Indigenous skateboard art featured on new stamps unveiled at Phoenix skate park

The Postal Service unveiled the “Art of the Skateboard" stamps at a Phoenix skate park, featuring designs from Indigenous artists.
2 days ago
(Facebook Photo/City of San Luis, Arizona)...
Associated Press

San Luis authorities receive complaints about 911 calls going across border

Authorities in San Luis say they are receiving more complaints about 911 calls mistakenly going across the border.
8 days ago
(Pexels Photo)...
Associated Press

Daylight saving time begins in most of US this weekend

No time change is observed in Hawaii, most of Arizona, Puerto Rico, the U.S. Virgin Islands, American Samoa, Guam and the Northern Marianas.
16 days ago
Mexican army soldiers prepare a search mission for four U.S. citizens kidnapped by gunmen in Matamo...
Associated Press

How the 4 abducted Americans in Mexico were located

The anonymous tip that led Mexican authorities to a remote shack where four abducted Americans were held described armed men and blindfolds.
16 days ago
Tom Brundy points to a newly built irrigation canal on one of the fields at his farm Tuesday, Feb. ...
Associated Press

Southwest farmers reluctant to idle farmland to save water

There is a growing sense that fallowing will have to be part of the solution to the increasingly desperate drought in the West.
23 days ago

Sponsored Articles

...
Fiesta Bowl Foundation

Celebrate 50 years of Vrbo Fiesta Bowl Parade magic!

Since its first production in the early 1970s, the Vrbo Fiesta Bowl Parade presented by Lerner & Rowe has been a staple of Valley traditions, bringing family fun and excitement to downtown Phoenix.
...
Quantum Fiber

How high-speed fiber internet edges out cable for everyday use

In a world where technology drives so much of our daily lives, a lack of high-speed internet can be a major issue.
...
Day & Night Air Conditioning, Heating and Plumbing

Prep the plumbing in your home just in time for the holidays

With the holidays approaching, it's important to know when your home is in need of heating and plumbing updates before more guests start to come around.
Pfizer to spend $11.6B on migraine treatment maker Biohaven